vs
Side-by-side financial comparison of SBC Medical Group Holdings Inc (SBC) and SANDRIDGE ENERGY INC (SD). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $39.4M, roughly 1.0× SANDRIDGE ENERGY INC). SANDRIDGE ENERGY INC runs the higher net margin — 54.9% vs 35.9%, a 19.0% gap on every dollar of revenue. On growth, SANDRIDGE ENERGY INC posted the faster year-over-year revenue change (1.1% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $14.4M). Over the past eight quarters, SANDRIDGE ENERGY INC's revenue compounded faster (14.1% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
SandRidge Energy, Inc. is a company engaged in hydrocarbon exploration in the Mid-Continent region of the United States. It is organized in Delaware and headquartered in Oklahoma City, Oklahoma.
SBC vs SD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.6M | $39.4M |
| Net Profit | $14.2M | $21.6M |
| Gross Margin | 73.1% | — |
| Operating Margin | 32.5% | 38.5% |
| Net Margin | 35.9% | 54.9% |
| Revenue YoY | -10.9% | 1.1% |
| Net Profit YoY | 117.2% | 23.1% |
| EPS (diluted) | $0.15 | $0.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.6M | $39.4M | ||
| Q3 25 | $43.4M | $39.8M | ||
| Q2 25 | $43.4M | $34.5M | ||
| Q1 25 | $47.3M | $42.6M | ||
| Q4 24 | $44.4M | $39.0M | ||
| Q3 24 | $53.1M | $30.1M | ||
| Q2 24 | $53.1M | $26.0M | ||
| Q1 24 | $54.8M | $30.3M |
| Q4 25 | $14.2M | $21.6M | ||
| Q3 25 | $12.8M | $16.0M | ||
| Q2 25 | $2.5M | $19.6M | ||
| Q1 25 | $21.5M | $13.0M | ||
| Q4 24 | $6.5M | $17.6M | ||
| Q3 24 | $2.8M | $25.5M | ||
| Q2 24 | $18.5M | $8.8M | ||
| Q1 24 | $18.8M | $11.1M |
| Q4 25 | 73.1% | — | ||
| Q3 25 | 70.6% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 79.7% | — | ||
| Q4 24 | 76.3% | — | ||
| Q3 24 | 81.5% | — | ||
| Q2 24 | 74.2% | — | ||
| Q1 24 | 72.1% | — |
| Q4 25 | 32.5% | 38.5% | ||
| Q3 25 | 36.6% | 37.8% | ||
| Q2 25 | 33.6% | 53.7% | ||
| Q1 25 | 51.1% | 28.6% | ||
| Q4 24 | 10.6% | 25.9% | ||
| Q3 24 | 26.1% | 28.3% | ||
| Q2 24 | 51.4% | 23.9% | ||
| Q1 24 | 44.6% | 27.8% |
| Q4 25 | 35.9% | 54.9% | ||
| Q3 25 | 29.6% | 40.1% | ||
| Q2 25 | 5.7% | 56.6% | ||
| Q1 25 | 45.4% | 30.6% | ||
| Q4 24 | 14.7% | 45.1% | ||
| Q3 24 | 5.3% | 84.8% | ||
| Q2 24 | 34.8% | 33.9% | ||
| Q1 24 | 34.2% | 36.7% |
| Q4 25 | $0.15 | $0.59 | ||
| Q3 25 | $0.12 | $0.43 | ||
| Q2 25 | $0.02 | $0.53 | ||
| Q1 25 | $0.21 | $0.35 | ||
| Q4 24 | $0.05 | $0.46 | ||
| Q3 24 | $0.03 | $0.69 | ||
| Q2 24 | $0.20 | $0.24 | ||
| Q1 24 | $0.20 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.1M | $111.0M |
| Total DebtLower is stronger | $42.8M | — |
| Stockholders' EquityBook value | $248.3M | $510.9M |
| Total Assets | $380.4M | $644.0M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.1M | $111.0M | ||
| Q3 25 | $127.4M | $101.2M | ||
| Q2 25 | $152.7M | $102.8M | ||
| Q1 25 | $132.1M | $99.7M | ||
| Q4 24 | $125.0M | $98.1M | ||
| Q3 24 | $137.4M | $92.7M | ||
| Q2 24 | — | $209.9M | ||
| Q1 24 | — | $207.0M |
| Q4 25 | $42.8M | — | ||
| Q3 25 | $21.1M | — | ||
| Q2 25 | $7.1M | — | ||
| Q1 25 | $6.9M | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $823.2K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $248.3M | $510.9M | ||
| Q3 25 | $248.0M | $492.4M | ||
| Q2 25 | $244.6M | $480.2M | ||
| Q1 25 | $226.4M | $464.9M | ||
| Q4 24 | $195.1M | $460.5M | ||
| Q3 24 | $205.0M | $446.8M | ||
| Q2 24 | $8.8M | $424.8M | ||
| Q1 24 | $9.0M | $419.7M |
| Q4 25 | $380.4M | $644.0M | ||
| Q3 25 | $321.4M | $619.0M | ||
| Q2 25 | $315.3M | $602.3M | ||
| Q1 25 | $284.6M | $588.3M | ||
| Q4 24 | $266.1M | $581.5M | ||
| Q3 24 | $296.5M | $565.2M | ||
| Q2 24 | $19.5M | $529.6M | ||
| Q1 24 | $19.8M | $527.4M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $31.7M |
| Free Cash FlowOCF − Capex | $51.2M | $14.4M |
| FCF MarginFCF / Revenue | 129.3% | 36.6% |
| Capex IntensityCapex / Revenue | 2.0% | 43.8% |
| Cash ConversionOCF / Net Profit | 3.66× | 1.46× |
| TTM Free Cash FlowTrailing 4 quarters | $23.3M | $41.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.0M | $31.7M | ||
| Q3 25 | $-20.9M | $25.3M | ||
| Q2 25 | $-8.3M | $22.9M | ||
| Q1 25 | $1.9M | $20.3M | ||
| Q4 24 | $-7.3M | $26.0M | ||
| Q3 24 | $5.0M | $20.8M | ||
| Q2 24 | $19.2M | $11.4M | ||
| Q1 24 | $3.7M | $15.7M |
| Q4 25 | $51.2M | $14.4M | ||
| Q3 25 | $-20.9M | $5.9M | ||
| Q2 25 | $-8.6M | $7.3M | ||
| Q1 25 | $1.7M | $13.9M | ||
| Q4 24 | $-7.9M | $13.2M | ||
| Q3 24 | $4.6M | $10.8M | ||
| Q2 24 | $18.3M | $9.0M | ||
| Q1 24 | $3.0M | $14.6M |
| Q4 25 | 129.3% | 36.6% | ||
| Q3 25 | -48.3% | 14.9% | ||
| Q2 25 | -19.9% | 21.0% | ||
| Q1 25 | 3.5% | 32.7% | ||
| Q4 24 | -17.8% | 33.8% | ||
| Q3 24 | 8.7% | 36.1% | ||
| Q2 24 | 34.5% | 34.5% | ||
| Q1 24 | 5.4% | 48.1% |
| Q4 25 | 2.0% | 43.8% | ||
| Q3 25 | 0.1% | 48.6% | ||
| Q2 25 | 0.7% | 45.2% | ||
| Q1 25 | 0.5% | 15.0% | ||
| Q4 24 | 1.3% | 32.9% | ||
| Q3 24 | 0.8% | 33.3% | ||
| Q2 24 | 1.6% | 9.4% | ||
| Q1 24 | 1.3% | 3.7% |
| Q4 25 | 3.66× | 1.46× | ||
| Q3 25 | -1.63× | 1.58× | ||
| Q2 25 | -3.39× | 1.17× | ||
| Q1 25 | 0.09× | 1.56× | ||
| Q4 24 | -1.12× | 1.48× | ||
| Q3 24 | 1.77× | 0.82× | ||
| Q2 24 | 1.04× | 1.30× | ||
| Q1 24 | 0.20× | 1.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
SD
| Oil Reserves | $19.0M | 48% |
| Natural Gas Reserves | $11.6M | 30% |
| Natural Gas Liquids Reserves | $8.7M | 22% |
